Pacific Edge moves cancer test kit sales online as it pushes for $100m target

A New Zealand maker of non-invasive bladder cancer test kits hopes that making its technology available online will help it reach its target of $100 million per year sales revenue.

Cancer diagnostic developer and service provider Pacific Edge [NZX:PEB] is launching an e-commerce site later this month to let New Zealanders order its Cxbladder product online.


Want to read more?

Choose a Subscription type that's right for you HERE
Already have an account? Login